Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 4083-4092

  Biswas, Subhra K ^a,b   Bist, Pradeep ^c   Dhillon, Manprit Kaur ^a   Kajiji, Tasneem ^a   Del Fresno, Carlos ^d   Yamamoto, Masahiro ^e   Lopez Collazo, Eduardo ^d   Akira, Shizuo ^e   Tergaonkar, Vinay ^c  

^a AGENCY FOR SCIENCE   (Singapore)

^b BIOINFORMATICS INSTITUTE   (Singapore)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; BETA INTERFERON; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; LIPID A; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MYELOID DIFFERENTIATION FACTOR 88; POLYINOSINIC POLYCYTIDYLIC ACID; RECOMBINANT BETA INTERFERON; STAT1 PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CHEMOKINE; CYTOKINE; IRF3 PROTEIN, MOUSE; LIGAND; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; UNCLASSIFIED DRUG; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL LINE; CELLS, CULTURED; CHEMOKINES; CYTOKINES; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; LIGANDS; LIPID A; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; POLY I-C; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 4;

EID: 35748984420     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.4083     Document Type: Article

References (54)

1. Cavaillon, J. M., C. Adrie, C. Fitting, and M. Adib-Conquy. 2003. Endotoxin tolerance: is there a clinical relevance? J. Endotoxin Res. 9: 101-107.
2. Dobrovolskaia, M. A., A. E. Medvedev, K. E. Thomas, N. Cuesta, V. Toshchakov, T. Ren, M. J. Cody, S. M. Michalek, N. R. Rice, and S. N. Vogel. 2003. Induction of in vitro reprogramming by Toll-like receptor TLR2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-κB signaling pathway components. J. Immunol. 170: 508-519.
3. Granowitz, E. V., R. Porat, J. W. Mier, S. F. Orencole, G. Kaplanski, E. A. Lynch, K. Ye, E. Vannier, S. M. Wolff, and C. A. Dinarello. 1993. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151: 1637-1645.
4. Erroi, A., G. Fantuzzi, M. Mengozzi, M. Sironi, S. F. Orencole, B. D. Clark, C. A. Dinarello, A. Isetta, P. Gnocchi, M. Giovarelli, et al. 1993. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect. Immun. 61: 4356-4359.
5. Kawasaki, T., M. Ogata, C. Kawasaki, T. Tomihisa, K. Okamoto, and A. Shigematsu. 2001. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth. Analg. 92: 1322-1326.
6. Wilson, C. S., S. C. Seatter, J. L. Rodriguez, J. Bellingham, L. Clair, and M. A. West. 1997. In vivo endotoxin tolerance: impaired LPS-stimulated TNF release of monocytes from patients with sepsis, but not SIRS. J. Surg. Res. 69: 101-106.
7. Beutler, B. 2004. SHIP, TGF-β, and endotoxin tolerance. Immunity 21: 134-135.
8. Beutler, B., K. Hoebe, and L. Shamel. 2004. Forward genetic dissection of afferent immunity: the role of TIR adapter proteins in innate and adaptive immune responses. C. R. Biol. 327: 571-580.
9. Medzhitov, R., and C. Janeway, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8: 452-456.
10. Kawai, T., and S. Akira. 2005. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17: 338-344.
11. Beutler, B. 2002. TLR4 as the mammalian endotoxin sensor. Curr. Top. Microbiol. Immunol. 270: 109-120.
12. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
13. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
14. Casanova, J. L., and L. Abel. 2004. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4: 55-66.
15. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
16. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301: 640-643.
17. Dobrovolskaia, M. A., and S. N. Vogel. 2002. Toll receptors: CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4: 903-914.
18. Fan, H., and J. A. Cook. 2004. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10: 71-84.
19. Nomura, F., S. Akashi, Y. Sakao, S. Sato, T. Kawai, M. Matsumoto, K. Nakanishi, M. Kimoto, K. Miyake, K. Takeda, and S. Akira. 2000. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164: 3476-3479.
20. Calvano, J. E., D. M. Agnese, J. Y. Um, M. Goshima, R. Singhal, S. M. Coyle, M. T. Reddell, A. Kumar, S. E. Calvano, and S. F. Lowry. 2003. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and Toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 20: 415-419.
21. Medvedev, A. E., A. Lentschat, L. M. Wahl, D. T. Golenbock, and S. N. Vogel. 2002. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169: 5209-5216.
22. Medvedev, A. E., K. M. Kopydlowski, and S. N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 164: 5564-5574.
23. Yoza, B., K. LaRue, and C. McCall. 1998. Molecular mechanisms responsible for endotoxin tolerance. Prog. Clin. Biol. Res. 397: 209-215.
24. Sfeir, T., D. C. Saha, M. Astiz, and E. C. Rackow. 2001. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit. Care Med. 29: 129-133.
25. Schroder, M., C. Meisel, K. Buhl, N. Profanter, N. Sievert, H. D. Volk, and G. Grutz. 2003. Different modes of IL-10 and TGF-β to inhibit cytokine-dependent IFN-γ production: consequences for reversal of lipopolysaccharide desensitization. J. Immunol. 170: 5260-5267.
26. Lopez-Collazo, E., P. Fuentes-Prior, F. Arnalich, and C. del Fresno. 2006. Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state. Curr. Opin. Infect. Dis. 19: 237-244.
27. Mashima, R., K. Saeki, D. Aki, Y. Minoda, H. Takaki, T. Sanada, T. Kobayashi, H. Aburatani, Y. Yamanashi, and A. Yoshimura. 2005. FLN29, a novel interferon-and LPS-inducible gene acting as a negative regulator of Toll-like receptor signaling. J. Biol. Chem. 280: 41289-41297.
28. Nimah, M., B. Zhao, A. G. Denenberg, O. Bueno, J. Molkentin, H. R. Wong, and T. P. Shanley. 2005. Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock 23: 80-87.
29. Liew, F. Y., H. Liu, and D. Xu. 2005. A novel negative regulator for IL-1 receptor and Toll-like receptor 4. Immunol. Lett. 96: 27-31.
30. Yoza, B. K., J. Y. Hu, S. L. Cousart, and C. E. McCall. 2000. Endotoxin inducible transcription is repressed in endotoxin tolerant cells. Shock 13: 236-243.
31. Ziegler-Heitbrock, L. 2001. The p50-homodimer mechanism in tolerance to LPS. J. Endotoxin Res. 7: 219-222.
32. Yoza, B. K., J. Y. Hu, S. L. Cousart, L. M. Forrest, and C. E. McCall. 2006. Induction of RelB participates in endotoxin tolerance. J. Immunol. 177: 4080-4085.
33. Chan, C., L. Li, C. E. McCall, and B. K. Yoza. 2005. Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter. J. Immunol. 175: 461-468.
34. Biswas, S. K., and V. Tergaonkar. 2007. Myeloid differentiation factor 88-independent toll-like receptor pathway: sustaining inflammation or promoting tolerance. Int. J. Biochem. Cell Biol. 39: 1582-1592.
35. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869-871.
36. Karaghiosoff, M., R. Steinborn, P. Kovarik, G. Kriegshauser, M. Baccarini, B. Donabauer, U. Reichart, T. Kolbe, C. Bogdan, T. Leanderson, et al. 2003. Central role for type I interferons and Tyk2 in lipopolysaccharide- induced endotoxin shock. Nat. Immunol. 4: 471-477.
37. Covert, M. W., T. H. Leung, J. E. Gaston, and D. Baltimore. 2005. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309: 1854-1857.
38. Sato, S., O. Takeuchi, T. Fujita, H. Tomizawa, K. Takeda, and S. Akira. 2002. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int. Immunol. 14: 783-791.
39. Jiang, W., R. Sun, H. Wei, and Z. Tian. 2005. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of Toll-like receptor 4 expression on macrophages. Proc. Natl. Acad. Sci. USA 102: 17077-17082.
40. Bjorkbacka, H., K. A. Fitzgerald, F. Huet, X. Li, J. A. Gregory, M. A. Lee, C. M. Ordija, N. E. Dowley, D. T. Golenbock, and M. W. Freeman. 2004. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol. Genomics 19: 319-330.
41. Thomas, K. E., C. L. Galligan, R. D. Newman, E. N. Fish, and S. N. Vogel. 2006. Contribution of interferon-β to the murine macrophage response to the Toll-like receptor 4 agonist, lipopolysaccharide. J. Biol. Chem. 281: 31119-31130.
42. Weighardt, H., S. Kaiser-Moore, S. Schlautkotter, T. Rossmann-Bloeck, U. Schleicher, C. Bogdan, and B. Holzmann. 2006. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J. Immunol. 177: 5623-5630.
43. Biswas, S. K., L. Gangi, S. Paul, T. Schioppa, A. Saccani, M. Sironi, B. Bottazzi, A. Doni, B. Vincenzo, F. Pasqualini, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107: 2112-2122.
44. Saccani, S., S. Pantano, and G. Natoli. 2002. p38-dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3: 69-75.
45. Tergaonkar, V., R. G. Correa, M. Ikawa, and I. M. Verma. 2005. Distinct roles of IκB proteins in regulating constitutive NF-κB activity. Nat. Cell Biol. 7: 921-923.
46. Akira, S., and S. Sato. 2003. Toll-like receptors and their signaling mechanisms. Scand. J. Infect. Dis. 35: 555-562.
47. Li, L., R. Jacinto, B. Yoza, and C. E. McCall. 2003. Distinct post-receptor alterations generate gene- and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytes. J. Endotoxin Res. 9: 39-44.
48. Malmgaard, L. 2004. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24: 439-454.
49. Martin, M., J. Katz, S. N. Vogel, and S. M. Michalek. 2001. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J. Immunol. 167: 5278-5285.
50. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852.
51. Sato, S., F. Nomura, T. Kawai, O. Takeuchi, P. F. Muhlradt, K. Takeda, and S. Akira. 2000. Synergy and cross-tolerance between Toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J. Immunol. 165: 7096-7101.
52. Sly, L. M., M. J. Rauh, J. Kalesnikoff, C. H. Song, and G. Krystal. 2004. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21: 227-239.
53. Hacker, H., V. Redecke, B. Blagoev, I. Kratchmarova, L. C. Hsu, G. G. Wang, M. P. Kamps, E. Raz, H. Wagner, G. Hacker, et al. 2006. Specificity in toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439: 204-207.
54. Werner, S. L., D. Barken, and A. Hoffmann. 2005. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309: 1857-1861.